Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

被引：0
|
作者：
Antonio Daponte
Simona Signoriello
Luigi Maiorino
Bruno Massidda
Ester Simeone
Antonio Maria Grimaldi
Corrado Caracò
Giuseppe Palmieri
Antonio Cossu
Gerardo Botti
Antonella Petrillo
Secondo Lastoria
Ernesta Cavalcanti
Pasquale Aprea
Nicola Mozzillo
Ciro Gallo
Giuseppe Comella
Paolo Antonio Ascierto
机构：
[1] Istituto Nazionale Tumori Fondazione Pascale,Department of Melanoma
[2] Second University,Medical Statistics
[3] S.Gennaro Hospital Napoli,Medical Oncology
[4] University of Cagliari,Medical Oncology
[5] Institute of Biomolecular Chemistry,Unit of Cancer Genetics
[6] C.N.R.,Department of Pathology
[7] Azienda Ospedaliero Universitaria,Department of Pathology
[8] Istituto Nazionale Tumori Fondazione Pascale,Department of Radiology
[9] Istituto Nazionale Tumori Fondazione Pascale,Department of Nuclear Medicine
[10] Istituto Nazionale Tumori Fondazione Pascale,Laboratory Medicine Unit
[11] Istituto Nazionale Tumori Fondazione Pascale,Vascular Access Unit
[12] Istituto Nazionale Tumori Fondazione Pascale,undefined
[13] the Southern Italy Cooperative Oncology Group (SICOG),undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
Melanoma; Fotemustine; Dacarbazine; Interferon-α;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PHASE-II STUDY OF INTERFERON ALFA-2A AND DACARBAZINE IN ADVANCED MELANOMA
    BAJETTA, E
    DILEO, A
    ZAMPINO, MG
    GIANNOTTI, B
    BROGELLI, L
    ARDIZZONI, A
    SERTOLI, MR
    BERNENGO, MG
    BARDUAGNI, M
    MAIFREDI, G
    ZUMIANI, G
    COMELLA, G
    BUZZONI, R
    ZILEMBO, N
    CRISCUOLO, D
    MASSIMINI, G
    CASCINELLI, N
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1719 - 1720
  • [32] A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma
    Agarwala, SS
    Ferri, W
    Gooding, W
    Kirkwood, JM
    CANCER, 1999, 85 (09) : 1979 - 1984
  • [33] Dacarbazine-vindesine vs dacarbazine-vindesine-cisplatinum in disseminated melanoma - A randomized phase III trial
    Jungnelius, U
    Ringborg, U
    Aamdahl, S
    Rudenstam, CM
    Stierner, U
    Ingvar, C
    Malmstrom, P
    Andersson, R
    Karlsson, M
    Willman, K
    Wist, E
    Westberg, R
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 215 - 215
  • [34] Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma
    Chapman, PB
    Einhorn, LH
    Meyers, ML
    Saxman, S
    Destro, AN
    Panageas, KS
    Begg, CB
    Agarwala, SS
    Schuchter, LM
    Ernstoff, MS
    Houghton, AN
    Kirkwood, JM
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2745 - 2751
  • [35] Combined treatment with pegylated interferon-α-2a and dacarbazine in patients with advanced metastatic melanoma
    Hauschild, Axel
    Dummer, Reinhard
    Ugurel, Selma
    Kaehler, Katharina C.
    Egberts, Friederike
    Fink, Wolfram
    Both-Skalsky, Jeannine
    Laetsch, Barbara
    Schadendorf, Dirk
    CANCER, 2008, 113 (06) : 1404 - 1411
  • [36] RANDOMIZED PHASE-III TRIAL OF VINBLASTINE, BLEOMYCIN, AND CIS-DICHLORODIAMMINE-PLATINUM VERSUS DACARBAZINE IN MALIGNANT-MELANOMA
    LUIKART, SD
    KENNEALEY, GT
    KIRKWOOD, JM
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) : 164 - 168
  • [37] A PHASE-II STUDY OF THE SEQUENTIAL ADMINISTRATION OF DACARBAZINE AND FOTEMUSTINE IN THE TREATMENT OF CEREBRAL METASTASES FROM MALIGNANT-MELANOMA
    CHANG, J
    ATKINSON, H
    AHERN, R
    LORENTZOS, A
    GORE, ME
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) : 2093 - 2095
  • [38] THE COMBINED DACARBAZINE-INTERFERON-ALPHA-2A-TREATMENT IN ADVANCED MALIGNANT-MELANOMA
    GUDAT, W
    SCHRAMM, P
    WALTER, C
    KNOP, J
    TUMORDIAGNOSTIK & THERAPIE, 1992, 13 (04) : 162 - 165
  • [39] Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities
    Rossi, CR
    Lejeune, FJ
    Pontes, L
    Foletto, M
    De Salvo, GL
    Pilati, PL
    Mocellin, S
    Ribeiro, M
    Lopes, M
    Lise, M
    MELANOMA RESEARCH, 2003, 13 (03) : 293 - 297
  • [40] Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma
    Feun, LG
    Savaraj, N
    Hurley, J
    Marini, A
    CANCER INVESTIGATION, 2002, 20 (03) : 357 - 361
12345